Indeed, several studies have indicated the role of chronic low-grade inflammation in neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), in which the role of leptin has been highlighted [2,3,30,31]. This evidence concerns the gene LEP and early-onset autosomal dominant Alzheimer disease.